Cargando…
Clinicopathological classification of immune checkpoint inhibitor-associated myocarditis: possible refinement by measuring macrophage abundance
BACKGROUND: Immune checkpoint inhibitor (ICI) myocarditis is associated with high morbidity and mortality. While endomyocardial biopsy (EMB) is considered a gold standard for diagnosis, the sensitivity of EMB is not well defined. Additionally, the pathological features that correlate with the clinic...
Autores principales: | Jimenez, Jesus, Kostelecky, Nicolas, Mitchell, Joshua D., Zhang, Kathleen W., Lin, Chieh-Yu, Lenihan, Daniel J., Lavine, Kory J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009938/ https://www.ncbi.nlm.nih.gov/pubmed/36915213 http://dx.doi.org/10.1186/s40959-023-00166-1 |
Ejemplares similares
-
Expansion of Disease Specific Cardiac Macrophages in Immune Checkpoint Inhibitor Myocarditis
por: Ma, Pan, et al.
Publicado: (2023) -
Delayed Diagnosis and Recovery of Fulminant Immune Checkpoint Inhibitor-Associated Myocarditis on VA-ECMO Support
por: Ramayya, Tarun, et al.
Publicado: (2022) -
Myocarditis after Covid-19 mRNA Vaccination
por: Verma, Amanda K., et al.
Publicado: (2021) -
CCL17 Protects Against Viral Myocarditis by Suppressing the Recruitment of Regulatory T Cells
por: Feng, Guoshuai, et al.
Publicado: (2023) -
The Clinicopathological Profile of Eosinophilic Myocarditis
por: Sheikh, Haris, et al.
Publicado: (2018)